GB2179936B - Cephalosporin salts and injectable compositions - Google Patents
Cephalosporin salts and injectable compositionsInfo
- Publication number
- GB2179936B GB2179936B GB8618989A GB8618989A GB2179936B GB 2179936 B GB2179936 B GB 2179936B GB 8618989 A GB8618989 A GB 8618989A GB 8618989 A GB8618989 A GB 8618989A GB 2179936 B GB2179936 B GB 2179936B
- Authority
- GB
- United Kingdom
- Prior art keywords
- injectable compositions
- cephalosporin salts
- cephalosporin
- salts
- injectable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
- C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
- C07D501/46—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cephalosporin Compounds (AREA)
- Medicinal Preparation (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MYPI87002279A MY102212A (en) | 1985-08-05 | 1987-09-29 | Cephalosporin salts and injectable compositions. |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US76223585A | 1985-08-05 | 1985-08-05 |
Publications (3)
Publication Number | Publication Date |
---|---|
GB8618989D0 GB8618989D0 (en) | 1986-09-17 |
GB2179936A GB2179936A (en) | 1987-03-18 |
GB2179936B true GB2179936B (en) | 1989-04-26 |
Family
ID=25064475
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB8618989A Expired GB2179936B (en) | 1985-08-05 | 1986-08-04 | Cephalosporin salts and injectable compositions |
Country Status (34)
Country | Link |
---|---|
JP (1) | JPH0615548B2 (en) |
KR (1) | KR930003121B1 (en) |
AR (1) | AR243894A1 (en) |
AT (1) | AT390957B (en) |
AU (1) | AU597262B2 (en) |
BE (1) | BE905219A (en) |
CA (1) | CA1284994C (en) |
CH (1) | CH675581A5 (en) |
CS (2) | CS276849B6 (en) |
CY (1) | CY1614A (en) |
DD (2) | DD254941A5 (en) |
DE (1) | DE3626375A1 (en) |
DK (1) | DK162053C (en) |
EG (1) | EG18003A (en) |
ES (1) | ES2002112A6 (en) |
FI (1) | FI84484C (en) |
FR (1) | FR2585705B1 (en) |
GB (1) | GB2179936B (en) |
GR (1) | GR862055B (en) |
HK (1) | HK99691A (en) |
HU (1) | HU196602B (en) |
IE (1) | IE59222B1 (en) |
IL (1) | IL79608A (en) |
IT (1) | IT1197067B (en) |
LU (2) | LU88574I2 (en) |
MY (1) | MY102212A (en) |
NL (1) | NL8601991A (en) |
OA (1) | OA08672A (en) |
PT (1) | PT83134B (en) |
SE (1) | SE469633B (en) |
SG (1) | SG79791G (en) |
SU (1) | SU1516013A3 (en) |
YU (1) | YU45793B (en) |
ZA (1) | ZA865842B (en) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4959469A (en) * | 1984-12-27 | 1990-09-25 | Banyu Pharmaceutical Company, Ltd. | Crystalline cephalosporin compounds |
US4883868A (en) * | 1984-12-27 | 1989-11-28 | Banyu Pharmaceutical Co., Ltd. | 7-amino-3-(substituted isoindolinium)methyl-3-cephem derivatives |
US5244891A (en) * | 1985-08-05 | 1993-09-14 | Bristol-Myers Squibb Company | Injectable compositions of cefepime dihydrochloride hydrate |
US4910301A (en) * | 1985-08-05 | 1990-03-20 | Bristol-Myers Company | Cefepime cephalosporin salts |
US4808617A (en) * | 1985-12-18 | 1989-02-28 | Bristol-Myers Company | Lyophilized or precipitated cephalosporin zwitterion and salt combination |
DE3788279T2 (en) * | 1987-06-25 | 1994-06-16 | Banyu Pharma Co Ltd | CRYSTALLINE CEPHALOSPORINE COMPOSITIONS, METHODS AND INTERMEDIATE PRODUCTS FOR THEIR PRODUCTION. |
JPH02101081A (en) * | 1988-10-08 | 1990-04-12 | Meiji Seika Kaisha Ltd | Crystalline dihydrochloride of cephalosporin derivative and production thereof |
CA2011116C (en) * | 1989-03-06 | 1999-11-16 | Murray A. Kaplan | Lyophilized bmy-28142 dihydrochloride for parenteral use |
CA2101571A1 (en) * | 1992-09-08 | 1994-03-09 | Elizabeth A. Garofalo | Crystalline dihydrate of a cephalosporin dihydrate salt and injectable compositions thereof |
EP0638573A1 (en) * | 1993-08-10 | 1995-02-15 | Lucky Ltd. | Crystalline hydrates of cephalosporin and process for preparation thereof |
SI1699804T1 (en) | 2003-12-23 | 2008-08-31 | Sandoz Ag | Process for production of intermediates for use in cefalosporin synthesis |
WO2008056221A2 (en) * | 2006-11-06 | 2008-05-15 | Orchid Chemicals & Pharmaceuticals Limited | Crystalline sulfate salt of cephalosporin antibiotic |
DE102012101680A1 (en) * | 2012-02-29 | 2013-08-29 | Aicuris Gmbh & Co. Kg | Pharmaceutical preparation containing an antiviral dihydroquinazoline derivative |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2116180A (en) * | 1982-03-04 | 1983-09-21 | Bristol Myers Co | Cephalosporin derivatives |
GB2165245A (en) * | 1984-10-01 | 1986-04-09 | Glaxo Group Ltd | Chemical compounds |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS55151588A (en) * | 1979-05-14 | 1980-11-26 | Takeda Chem Ind Ltd | Preparation of cephalosporin salt crystal |
US4406899A (en) * | 1982-03-04 | 1983-09-27 | Bristol-Myers Company | Cephalosporins |
US4525473A (en) * | 1983-03-30 | 1985-06-25 | Bristol-Myers Company | Cephalosporins |
DE3419015A1 (en) * | 1984-05-22 | 1985-11-28 | Bayer Ag, 5090 Leverkusen | METHOD FOR PRODUCING CEPHALOSPORINES |
GB8424692D0 (en) * | 1984-10-01 | 1984-11-07 | Glaxo Group Ltd | Chemical compounds |
-
1986
- 1986-07-28 FR FR8610892A patent/FR2585705B1/en not_active Expired
- 1986-07-28 CA CA000514766A patent/CA1284994C/en not_active Expired - Lifetime
- 1986-07-29 AR AR86304717A patent/AR243894A1/en active
- 1986-07-30 AU AU60694/86A patent/AU597262B2/en not_active Expired
- 1986-07-31 YU YU137186A patent/YU45793B/en unknown
- 1986-08-01 IE IE207886A patent/IE59222B1/en not_active IP Right Cessation
- 1986-08-01 FI FI863155A patent/FI84484C/en not_active IP Right Cessation
- 1986-08-04 BE BE07217010A patent/BE905219A/en not_active IP Right Cessation
- 1986-08-04 IL IL79608A patent/IL79608A/en not_active IP Right Cessation
- 1986-08-04 PT PT83134A patent/PT83134B/en unknown
- 1986-08-04 SE SE8603308A patent/SE469633B/en not_active IP Right Cessation
- 1986-08-04 CS CS903570A patent/CS276849B6/en unknown
- 1986-08-04 ZA ZA865842A patent/ZA865842B/en unknown
- 1986-08-04 SU SU864027914A patent/SU1516013A3/en active
- 1986-08-04 CS CS865827A patent/CS276717B6/en unknown
- 1986-08-04 NL NL8601991A patent/NL8601991A/en not_active Application Discontinuation
- 1986-08-04 DE DE19863626375 patent/DE3626375A1/en not_active Ceased
- 1986-08-04 IT IT21409/86A patent/IT1197067B/en active Protection Beyond IP Right Term
- 1986-08-04 JP JP61183288A patent/JPH0615548B2/en not_active Expired - Lifetime
- 1986-08-04 GR GR862055A patent/GR862055B/en unknown
- 1986-08-04 GB GB8618989A patent/GB2179936B/en not_active Expired
- 1986-08-04 CH CH3117/86A patent/CH675581A5/de not_active IP Right Cessation
- 1986-08-04 LU LU88574C patent/LU88574I2/en unknown
- 1986-08-04 DK DK371886A patent/DK162053C/en not_active IP Right Cessation
- 1986-08-04 LU LU86540A patent/LU86540A1/en unknown
- 1986-08-05 HU HU863376A patent/HU196602B/en unknown
- 1986-08-05 KR KR1019860006445A patent/KR930003121B1/en not_active IP Right Cessation
- 1986-08-05 AT AT0211086A patent/AT390957B/en not_active IP Right Cessation
- 1986-08-05 DD DD86293433A patent/DD254941A5/en unknown
- 1986-08-05 OA OA58918A patent/OA08672A/en unknown
- 1986-08-05 ES ES8600872A patent/ES2002112A6/en not_active Expired
-
1987
- 1987-09-29 MY MYPI87002279A patent/MY102212A/en unknown
-
1988
- 1988-03-30 DD DD88314213A patent/DD268395A5/en unknown
-
1989
- 1989-08-04 EG EG489/86A patent/EG18003A/en active
-
1991
- 1991-10-02 SG SG797/91A patent/SG79791G/en unknown
- 1991-12-05 HK HK996/91A patent/HK99691A/en not_active IP Right Cessation
-
1992
- 1992-07-10 CY CY1614A patent/CY1614A/en unknown
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2116180A (en) * | 1982-03-04 | 1983-09-21 | Bristol Myers Co | Cephalosporin derivatives |
GB2165245A (en) * | 1984-10-01 | 1986-04-09 | Glaxo Group Ltd | Chemical compounds |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA89407B (en) | Cephalosporin salts and injectable compositions | |
NZ215333A (en) | Cephem compounds and pharmaceutical compositions | |
EG18003A (en) | Cephalosporin salts and injectable compositions | |
GB8519452D0 (en) | Injectable solutions | |
PH23045A (en) | Cephem derivative and composition containing said compound | |
NZ212320A (en) | Cephalosporin derivatives and pharmaceutical compositions | |
NZ215717A (en) | Cephalosporin derivatives | |
GR861727B (en) | 5-substituted-6-aminopyridine derivatives composition and uses | |
EP0209751A3 (en) | New cephalosporin derivatives and bactericides containing the same | |
NZ214048A (en) | Cephalosporins and pharmaceutical compositions | |
EP0230052A3 (en) | Immunoamplifiers and related compositions | |
PH23442A (en) | Cephalosporin derivatives and salts thereof | |
GB8511207D0 (en) | Particulate composition | |
NZ210761A (en) | Cephalosporin derivatives and pharmaceutical compositions | |
IL88959A (en) | Cephalosporin salts and injectable compositions | |
IL74822A0 (en) | Cephalosporin derivatives and salts thereof and their preparation | |
ZA852723B (en) | Cephalosporin derivatives and salts thereof | |
NZ216624A (en) | Cephalosporins and pharmaceutical compositions | |
HUT44607A (en) | Emulsifyer-anti-corrosive additive composition | |
IL78351A0 (en) | Cephalosporin derivatives | |
ZA862347B (en) | Cephalosporin derivatives | |
IL79200A0 (en) | Cephalosporin derivatives | |
IE850448L (en) | Cephalosporin derivatives | |
IE850040L (en) | Cephalosporin derivatives | |
IE841527L (en) | Cephalosporin salts |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
732 | Registration of transactions, instruments or events in the register (sect. 32/1977) | ||
CTFF | Supplementary protection certificate filed |
Free format text: SPC/GB95/017, 950620 |
|
CTFG | Supplementary protection certificate granted |
Free format text: SPC/GB94/011, 951101, EXPIRES:20080628 |
|
CTFG | Supplementary protection certificate granted |
Free format text: SPC/GB95/017, 951101, EXPIRES:20080628 |
|
PE20 | Patent expired after termination of 20 years |
Effective date: 20060803 |
|
CTFE | Supplementary protection certificate entered into force |
Free format text: SPC/GB95/017: 20060804, EXPIRES: 20080628 Spc suppl protection certif: SPC/GB95/017 Filing date: 20060804 Expiry date: 20080628 |
|
SPCE | Supplementary protection certificate expired |
Spc suppl protection certif: SPC/GB95/017 Filing date: 19950620 Expiry date: 20060804 Extension date: 20080628 |